Skip to main content
SpringerLink
Log in

Immunologic phenotypes of non-Hodgkin’s lymphomas: Correlation with morphology and function

  • Chapter
Book cover Malignant Lymphomas and Hodgkin’s Disease: Experimental and Therapeutic Advances

Part of the book series: Developments in Oncology ((DION,volume 32))

  • 59 Accesses

Abstract

The non-Hodgkin’s lymphomas (NHL) represent multiple diseases with diverse morphologic and clinical expressions. Morphologic classification schemes such as that proposed by Rappaport have been shown to be useful in predicting the clinical course [1]. However, in some instances distinctive morphologic entities may be very closely related clinically and/or biologically, whereas other diseases that share morphologic similarities may be clinically and biologically quite distinct (Table I). The application of modern immunologic techniques and concepts has enabled us to develop a conceptual framework which we may use to decipher the morphologic diversity of these neoplasms [2]. This review will focus on the non-Hodgkin’s lymphomas presenting primarily in adult life.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 469.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 599.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 599.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Rappaport H (1966). Tumors of the hematopoietic system. Atlas of tumor pathology. Section 3, fascicle 8. Washington, D.C.: Armed Forces Institute of Pathology.

    Google Scholar 

  2. Mann RB, Jaffe ES and Berard CW (1979). Malignant lymphomas: A conceptual understanding of morphologic diversity. Amer J Pathol 94: 103–192.

    CAS  Google Scholar 

  3. Rosenberg SA (1979). Current concepts in cancer: Non-Hodgkin’s Lymphoma–Selection of treatment on the basis of histologic type. N Engl J Med 301: 924–928.

    Article  PubMed  CAS  Google Scholar 

  4. Rosenberg SA, Berard CW, Brown BW et al. (1982). National Cancer Institute sponsored study of classification of non-Hodgkin’s lymphomas: Summary and description of a Working Formulation for clinical usage. Cancer 49: 2112–2135.

    Article  Google Scholar 

  5. Jaffe ES (1983). Follicular lymphomas: Possibility that they are benign tumors of the lymphoid system. J Nat Cancer Inst 70: 401–403.

    PubMed  CAS  Google Scholar 

  6. Braylan RC, Jaffe ES, Burbach JV et al. (1976). Similarities of surface characteristics of neoplastic well differentiated lymphocytes from solid tissues and from peripheral blood. Cancer Res 36: 1619–1625.

    PubMed  CAS  Google Scholar 

  7. Pangalis GA, Nathwani BN and Rappaport H (1977). Malignant lymphoma, well differentiated lymphocytic. Its relationship with chronic lymphocytic leukemia and macroglobulinemia of Waldenstrom. Cancer 39: 999–1000.

    Article  PubMed  CAS  Google Scholar 

  8. Cossman J and Jaffe ES (1981). Distribution of complement receptor subtypes in non-Hodgkin’s lymphomas of B cell origin. Blood 58: 20–26.

    PubMed  CAS  Google Scholar 

  9. Fu SM, Chiorazzi N, Kunkel HG et al. (1978). Induction of in vitro differentiation and immunoglobulin synthesis of human leukemic B lymphocytes. J Exp Med 148: 1570–1578.

    Article  PubMed  CAS  Google Scholar 

  10. Cossman J, Neckers LM, Braziel RM et al. (1984). In vitro enhancement of immunoglobulin gene expression in chronic lymphocytic leukemia. J Clin Invest 73:587–592.

    Article  PubMed  CAS  Google Scholar 

  11. Martin PJ, Hansen JA, Nowinski RC et al. (1980). A new human T cell differentiation antigen: Unexpected expression on chronic lymphocytic leukemia cells. Immunogenetics II: 429–439.

    Article  Google Scholar 

  12. Royston I, Majda JA, Baird SM et al. (1980). Human T cell antigens defined by monoclonal antigens: The 65,000 dalton antigen of T cells (T65) is also found on chronic lymphocytic leukemia cells bearing surface immunoglobulin. J Immunol 125: 725–731.

    PubMed  CAS  Google Scholar 

  13. Caligaris-Cappio F, Gobbi M, Bofil M and Janossy G (1982). Infrequent normal B lymphocytes express features of B-chronic lymphocytic leukemia. J Exp Med 155: 623–628.

    Article  PubMed  CAS  Google Scholar 

  14. Cossman J, Neckers LM, Hsu SM et al. (1984). Low grade lymphomas: Expression of developmentally regulated B-cell antigens. Amer J Pathol 114: 117–124.

    Google Scholar 

  15. Ferroni M, Viale G, Risso A and Pernis B (1976). A study of the immunoglobulin classes present on the membrane and in the cytoplasm of human tonsil plasma cells. Eur J Immunol 6: 562–565.

    Article  Google Scholar 

  16. Halper J, Fu SM, Wang CY et al. (1978). Patterns of expression of human ` Ia-like’ antigens during the terminal stages of B-cell development. J Immunol 120: 1480–1484.

    PubMed  CAS  Google Scholar 

  17. Stashenko P, Nadler LM, Hardy R and Schlossman SF (1981). Expression of cell surface markers after human B lymphocyte activation. Proc Nat Acad Sci USA 78: 3848–3852.

    Article  PubMed  CAS  Google Scholar 

  18. Abramson C, Kersey J and Le Bien T (1981). A monoclonal antibody (BA-1) reactive with cells of human B lymphocyte lineage. J Immunol 126: 83–88.

    PubMed  CAS  Google Scholar 

  19. Jaffe ES, Braylan RC, Nanba K et al. (1977). Functional markers: A new perspective on malignant lymphomas. Cancer Treat Rep 61: 953–962.

    PubMed  CAS  Google Scholar 

  20. Nanba K, Jaffe ES, Braylan RC et al. (1977). Alkaline phosphatase-positive malignant lymphomas. A subtype of B-cell lymphomas. Amer J Clin Pathol 68: 535–542.

    CAS  Google Scholar 

  21. Swerdlow SH, Haveshaw JA, Murray LJ et al. (1983). Centrocytic lymphoma: A distinct clinicopathologic and immunologic entity. Amer J Pathol 113: 181–197.

    CAS  Google Scholar 

  22. Jaffe ES, Shevach EM, Frank MM et al. (1974). Nodular lymphoma. Evidence for origin from follicular B-lymphocytes. N Engl J Med 290: 813–819.

    Article  PubMed  CAS  Google Scholar 

  23. Harris NL and Bhan AK (1983). Distribution of T-cell subsets in follicular and diffuse lymphomas of B-cell type. Amer J Pathol 113: 172–180.

    CAS  Google Scholar 

  24. Braziel RM, Neckers LM, Jaffe ES and Cossman J (1983). Follicular (nodular) B-cell lymphomas: Immunoregulation of immunoglobulin secretion. Blood 62 (Suppl. 1): 187a.

    Google Scholar 

  25. DeVita VT, Canellos OP, Chabner BA et al. (1975). Advanced diffuse histiocytic lymphoma, a potentially curable disease. Lancet 1: 248–250.

    Article  PubMed  Google Scholar 

  26. Jaffe ES (1980). Non-Hodgkin’s lymphomas as neoplasms of the immune system, pp 222–226. In: Berard CW, moderator. A multidisciplinary approach to non-Hodgkin’s lymphomas. Ann Intern Med 94: 218–235.

    Google Scholar 

  27. Jaffe ES, Strauchen JA and Berard CW (1982). Predictability of immunologic phenotype of morphologic criteria in diffuse aggressive non-Hodgkins’s lymphomas. Amer J Clin Pathol 77: 46–49.

    CAS  Google Scholar 

  28. Cossman J, Jaffe ES and Fisher RI. Immunologic phenotypes of diffuse aggressive non-Hodgkin’s lymphomas: Correlation with clinical features. Cancer (in press)..

    Google Scholar 

  29. Waldron JA, Leech JE, Glick AD et al. (1977). Malignant lymphoma of peripheral T-lymphocyte origin. Cancer 40: 1604–1617.

    Article  PubMed  CAS  Google Scholar 

  30. Pinkus GS, Said JW and Hargreaves H (1979). Malignant lymphoma, T-cell type. A distinct morphologic variant with large multilobulated nuclei, with a report of four cases. Amer J Clin Pathol 72: 540–550.

    CAS  Google Scholar 

  31. Jaffe ES, Cossman J and Fisher RI (1981). Immunologic, pathologic and clinical analysis of peripheral T-cell lymphomas. Blood 58 (Suppl. I): 551.

    Google Scholar 

  32. Doggett RS, Wood GS, Horning S et al. (1984). The immunologic characterization of 95 nodal and extranodal diffuse large cell lymphomas in 89 patients. Amer J Pathol 115: 245–252.

    CAS  Google Scholar 

  33. Jaffe ES, Longo DL, Cossman J et al. (1984). Diffuse B-cell lymphomas with T-cell predominance in patients with follicular lymphomas or “ pseudo T-cell lymphomas ”. Lab Invest 50: 27–28a.

    Google Scholar 

  34. Arnold A, Cossman J, Bakhshi A et al. (1983). Immunoglobulin gene rearrangements as unique clonal markers in human lymphoid neoplasma. N Engl J Med 309: 1593–1599.

    Article  PubMed  CAS  Google Scholar 

  35. Uchiyama T, Yodoi J, Sagawa K et al. (1977). Adult T-cell leukemia: Clinical and hematologic features of 16 cases. Blood 50: 481–492.

    PubMed  CAS  Google Scholar 

  36. Catovsky O, Greaves MF, Rose M et al. (1982). Adult T-cell lymphoma-leukemia in blacks from the West Indies. Lancet 1: 639–643.

    Article  PubMed  CAS  Google Scholar 

  37. Blayney DW, Jaffe ES, Blattner Wa et al. (1983). The human T-cell leukemia/lymphoma virus (HTLV) associated with American adult T-cell leukemia/lymphoma ( ATL ). Blood 62: 401–405.

    PubMed  CAS  Google Scholar 

  38. Hanaoka M, Sasaki M, Matsumoto H et al. (1979). Adult T-cell leukemia: Histological classification and characteristics. Acta Pathol Jap 19 (5): 727–738.

    Google Scholar 

  39. Jaffe ES, Blattner WA, Blayney DW et al. (1984). The pathologic spectrum of HTLV-associated leukemia/lymphoma in the United States. Amer J Surg Pathol 8: 263–275.

    Article  CAS  Google Scholar 

  40. Uchiyama T, Sagawak, Takatsuki K and Uchino H (1978). Effect of adult T-cell leukemia cells pokeweed mitogen-induced B-cell differentiation. Clin Immunol Immunopathol 10: 24–34.

    Article  PubMed  CAS  Google Scholar 

  41. Waldmann TA (1984). Function and phenotype of virus-associated neoplastic cells, pp. 553554. In: Broder S, moderator. T-cell lymphoproliferative syndrome associated with human T-cell leukemia/lymphoma virus. Ann Intern Med 100: 543–557.

    Google Scholar 

  42. Grossman B, Schecter GP, Horton JE et al. (1981). Hypercalcemia associated with T-cell lymphoma-leukemia. Amer J Clin Pathol 75: 149–155.

    CAS  Google Scholar 

  43. Kassel SH, Echevarria RA and Guzzo FF (1969). Midline malignant reticulosis (so-called lethal midline granuloma). Cancer 23: 920–935.

    Article  PubMed  CAS  Google Scholar 

  44. Liebow AA, Carrington CB and Friedman RJ (1972). Lymphomatoid granulomatosis. Hum Pathol 3: 457–558.

    Article  PubMed  CAS  Google Scholar 

  45. De Remee RA, Weiland LH and McDonald TJ (1978). Polymorphic reticulosis, lymphomatoid granulomatosis: Two diseases or one? Mayo Clin Proc 53: 634–640.

    Google Scholar 

  46. Saldana MJ, Patchefsky AS, Israel H et al. (1977). Pulmonary angitis and granulomatosis. The relationship between histological features, organ involvement and response to treatment. Hum Pathol 8: 391–409.

    Article  PubMed  CAS  Google Scholar 

  47. Katzenstein A, Carrington CB and Liebow AA (1979). Lymphomatoid granulomatosis: A clinicopathologic study of 152 cases. Cancer 43: 360–373.

    Article  PubMed  CAS  Google Scholar 

  48. Fauci AS, Haynes BF, Costa J et al. (1982). Lymphomatoid granulomatosis, prospective clinical and therapeutic experience over ten years. N Engl J Med 306: 68–74.

    Article  PubMed  CAS  Google Scholar 

  49. Jaffe ES, Costa JC, Fauci A et al. (1983). Malignant lymphoma and erythrophagocytosis simulating malignant histiocytosis. Amer J Med 75: 741–748.

    Article  PubMed  CAS  Google Scholar 

  50. Colby TV and Carrington CB (1982). Pulmonary lymphomas simulating lymphomatoid granulomatosis. Amer J Surg Pathol 6: 19–32.

    Article  CAS  Google Scholar 

  51. Jaffe ES. The pathologic and clinical spectrum of post-thymic T-cell malignancies. Cancer Invest. (in press).

    Google Scholar 

  52. Simrell CR, Crabtree GR, Cossman J et al. (1982). Stimulation of phagocytosis by a T-cell lymphoma derived lymphokine. In: Vitetta E (Ed.). B and T-Cell Tumors, 24:247–252. UCLA Symposia in Molecular and Cellular Biology. New York: Academic Press.

    Google Scholar 

  53. Risdall RJ, McKenna RW, Nesbit ME et al. (1979). Virus associated hemophagocytic syndrome, a benign histiocytic proliferation distinct from malignant histiocytosis. Cancer 44: 993–1002.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Laboratory of Pathology, National Cancer Institute, Bethesda, Maryland, USA

    E. S. Jaffe, O. J. Cossman, L. M. Neckers, R. M. Braziel & C. R. Simrell

Authors
  1. E. S. Jaffe
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. O. J. Cossman
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. L. M. Neckers
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. R. M. Braziel
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. C. R. Simrell
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Division of Oncology, Ospedale San Giovanni, Bellinzona, Switzerland

    Franco Cavalli

  2. Istituto Nazionale, per lo Studio e la Cura dei Tumori, Milano, Italy

    G. Bonadonna

  3. Pharmaceutical Research & Development Division, Bristol-Myers Company, Syracuse, NY, USA

    Marcel Rozencweig

Rights and permissions

Reprints and permissions

Copyright information

© 1985 Martinus Nijhoff Publishers, Boston

About this chapter

Cite this chapter

Jaffe, E.S., Cossman, O.J., Neckers, L.M., Braziel, R.M., Simrell, C.R. (1985). Immunologic phenotypes of non-Hodgkin’s lymphomas: Correlation with morphology and function. In: Cavalli, F., Bonadonna, G., Rozencweig, M. (eds) Malignant Lymphomas and Hodgkin’s Disease: Experimental and Therapeutic Advances. Developments in Oncology, vol 32. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-2607-6_4

Download citation

  • DOI: https://doi.org/10.1007/978-1-4613-2607-6_4

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4612-9632-4

  • Online ISBN: 978-1-4613-2607-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation